Faculty

Back to Index
Louis VanderMolen, MD
Professor of Clinical Medicine
Medicine
NOR 1441 Eastlake Ave Health Sciences Campus Los Angeles

Overview

Dr. VanderMolen earned his medical degree from Loyola University Stritch School of Medicine. He performed his Internal Medicine Internship and Residency from Baylor College of Medicine- Texas Medical Center. He then went on to complete two fellowships, the first in hematology at Baylor, and the second in oncology at National Cancer Institute- Clinical Oncology Program.

Awards

Phi Beta Kappa: Elected Member, 1977

Baylor College of Medicine: Chief Resident, Internal Medicine, 1983-1984

Orange County Medical Association: Physician of Excellence Award, 2006-2013

Orange County Medical Association: award conferred by, 2006-2013

Baylor College of Medicine: award conferred by, 1983-1984

Baylor College of Medicine: Department, 1983-1984

Orange County Medical Association: Department, 2006-2013

Phi Beta Kappa: Department, 1977

Phi Beta Kappa: award or honor for, 1977

Orange County Medical Association: award or honor for, 2006-2013

Baylor College of Medicine: award or honor for, 1983-1984

Phi Beta Kappa: full name, 1977

Phi Beta Kappa: person in primary position, 1977

Orange County Medical Association: person in primary position, 2006-2013

Baylor College of Medicine: person in primary position, 1983-1984

Phi Beta Kappa: last name, 1977

Orange County Medical Association: last name, 2006-2013

Baylor College of Medicine: last name, 1983-1984

Phi Beta Kappa: HR job title, 1977

Baylor College of Medicine: HR job title, 1983-1984

Orange County Medical Association: HR job title, 2006-2013

Baylor College of Medicine: full name, 1983-1984

Orange County Medical Association: Faculty Rank4/rdfs:label>, 2006-2013

Phi Beta Kappa: position in department, 1977

Baylor College of Medicine: position in department, 1983-1984

Orange County Medical Association: position in department, 2006-2013

Orange County Medical Association: full name, 2006-2013

Baylor College of Medicine: sort order, 1983-1984

Phi Beta Kappa: sort order, 1977

Orange County Medical Association: Organization, 2006-2013

Phi Beta Kappa: Organization, 1977

Baylor College of Medicine: Organization, 1983-1984

Baylor College of Medicine: email address, 1983-1984

Phi Beta Kappa: email address, 1977

Orange County Medical Association: email address, 2006-2013

Phi Beta Kappa: start date, 1977

Baylor College of Medicine: start date, 1983-1984

Orange County Medical Association: start date, 2006-2013

Orange County Medical Association: type, 2006-2013

Baylor College of Medicine: type, 1983-1984

Phi Beta Kappa: type, 1977

Baylor College of Medicine: end date, 1983-1984

Orange County Medical Association: end date, 2006-2013

Phi Beta Kappa: workplace homepage, 1977

Baylor College of Medicine: workplace homepage, 1983-1984

Orange County Medical Association: workplace homepage, 2006-2013

Phi Beta Kappa: Professor, 1977

Orange County Medical Association: Professor, 2006-2013

Baylor College of Medicine: Professor, 1983-1984

Phi Beta Kappa: award conferred by, 1977

Phi Beta Kappa: Faculty Rank, 1977

Orange County Medical Association: Faculty Rank, 2006-2013

Baylor College of Medicine: Faculty Rank, 1983-1984

Baylor College of Medicine: is primary position, 1983-1984

Orange County Medical Association: is primary position, 2006-2013

Phi Beta Kappa: is primary position, 1977

Phi Beta Kappa: preferred title, 1977

Orange County Medical Association: preferred title, 2006-2013

Baylor College of Medicine: preferred title, 1983-1984

Phi Beta Kappa: Agent, 1977

Baylor College of Medicine: Agent, 1983-1984

Orange County Medical Association: Agent, 2006-2013

Orange County Medical Association: first name, 2006-2013

Phi Beta Kappa: first name, 1977

Baylor College of Medicine: first name, 1983-1984

Phi Beta Kappa: position in organization, 1977

Baylor College of Medicine: position in organization, 1983-1984

Orange County Medical Association: position in organization, 2006-2013

Phi Beta Kappa: Person ID, 1977

Baylor College of Medicine: Person ID, 1983-1984

Orange County Medical Association: Person ID, 2006-2013

Baylor College of Medicine: VanderMolen, Louis, 1983-1984

Orange County Medical Association: VanderMolen, Louis, 2006-2013

Phi Beta Kappa: VanderMolen, Louis, 1977

Phi Beta Kappa: Medicine, 1977

Baylor College of Medicine: Keck School of Medicine of USC, 1983-1984

Orange County Medical Association: Keck School of Medicine of USC, 2006-2013

Phi Beta Kappa: Position, 1977

Baylor College of Medicine: Position, 1983-1984

Orange County Medical Association: Position, 2006-2013

Phi Beta Kappa: Professor of Clinical Medicine, 1977

Baylor College of Medicine: Professor of Clinical Medicine, 1983-1984

Orange County Medical Association: Professor of Clinical Medicine, 2006-2013

Orange County Medical Association: has faculty rank, 2006-2013

Phi Beta Kappa: has faculty rank, 1977

Baylor College of Medicine: has faculty rank, 1983-1984

Orange County Medical Association: sort order, 2006-2013

Publications

Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic melanoma? Cancer Biother Radiopharm. Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic melanoma? Cancer Biother Radiopharm. 2012 Aug; 27(6):337-43. View in: PubMed

A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced head and neck cancer. Am J Otolaryngol. 2012 Jan-Feb; 33(1):93-7. View in: PubMed

Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic renal cell cancer? Cancer Biother Radiopharm. Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic renal cell cancer? Cancer Biother Radiopharm. 2011 Jun; 26(3):273-7. View in: PubMed

High-dose chemotherapy and autologous stem cell rescue for metastatic breast cancer: superior survival for tandem compared with single transplants. Am J Clin Oncol. 2005 Jun; 28(3):281-8. View in: PubMed

Autologous tumor cell line-derived vaccine for patient-specific treatment of advanced renal cell carcinoma. Cancer Biother Radiopharm. 2004 Oct; 19(5):570-80. View in: PubMed

Does continuous-infusion interleukin-2 increase survival in metastatic melanoma? Am J Clin Oncol. Does continuous-infusion interleukin-2 increase survival in metastatic melanoma? Am J Clin Oncol. 2003 Apr; 26(2):141-5. View in: PubMed

Successful treatment of transitional cell carcinoma of the urethra with chemotherapy. Cancer Invest. 2002; 20(2):206-7. View in: PubMed

Powered bySC CTSI